Get comprehensive development support

Meet rigorous product specifications and ensure efficient process intensification to optimize manufacturing costs. To meet these needs, our experts provide comprehensive drug process development to continually improve your operational efficiency.

Expert drug process development, optimization and validation

Access our expert drug process development, optimization and validation as part of our integrated services spanning feasibility studies, clinical trial manufacture and commercial production of drug substances, intermediates and finished drug products.

There is a need for drug-manufacturing processes that produce the next generation of innovative products. Now, more than ever, these processes must be innovative, efficient, reliable, and cost-effective allowing you to meet rigorous and more specialized product specifications. To meet these needs, our experts provide comprehensive process development to continually improve the operational efficiency in producing your drug products.

This on-demand webinar focuses on the manufacturing aspects of amorphous spray-dried dispersions (SDDs) to enable successful scale-up and optimization of the process.

View our webinar on-demand

Manufacturing amorphous solid dispersions by spray-drying: scale-up approaches

Select the optimal drug process and enabling technologies

Process development begins with selecting the optimal process and enabling technologies during product design and proceeds through each stage of development, including scale-up from bench and pilot scale through commercial manufacture under cGMP conditions.

Our multidisciplinary product development teams are well versed in the interplay between:

  • Material science / material design and functionality
  • Product development and optimization
  • GMP manufacturing requirements
  • Process development and control

Streamline your process and reduce the need for changes as your drug candidate advances

Because we have the facilities, technologies and services to take a product from conception through commercial development, process-development decisions–while phase-appropriate–are made with the ultimate goal of commercial manufacture in mind. This approach streamlines the overall process and reduces the need for formulation and process changes as the drug candidate is advanced.

A range of innovative process-development tools and evaluations are utilized in our approach to process development and optimization:

  • Computer-assisted process evaluation tools
  • Scale-up and scale-down tools for specific unit operations
  • Analytical method development supporting QA and QC activities 
  • Process analyses and troubleshooting to improve process efficiency 
  • Operational support to implement or maintain standards for cGMP compliance 
  • Process analytical tools to enhance process efficiency, productivity, and reliability
  • Troubleshooting and resolving real-time production issues across a broad range of unit operations 
Process scale-up and validation best practices have been developed and implemented over a 20+ year span across our technologies.

oral drug products and intermediates

process development and optimization centers of excellence

Bend, OR, USA

Production, Sales & Support, Research & Development

1201 NW Wall St.
Bend, OR 97703
United States of America (the)

Tampa, FL, USA

Production, Sales & Support

4910 Savarese Circle
Tampa, FL 33634
United States of America (the)

Quakertown, PA, USA


20 Pacific Dr.
Quakertown, PA 18951
United States of America (the)

Monteggio, Switzerland

Production, Research & Development, Sales & Support

Via Cantonale 4
Monteggio 6998

related content

Application of Fundamental Relationships and Models to Predict Spray-Dried Dispersion Particle Size​
Presentation slides
High-Temperature Measurement of API Solubility in Organic Solvents for Spray-Drying Process Development
Impact of Process Parameters on Particle Morphology and Filament Formation in Spray-Dried Eudragit L100 Polymer
Peer-reviewed pub
The Impact of the Fed and Fasted State on BCS Class II Cyclosporine Formulation Performance In Vitro